Cresilon
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
122 18th St, Brooklyn, New York, 11215, ...Phone Number
(347) 435-2226Website
www.cresilon.comRevenue
$40.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
4
1
1
1
1
About Cresilon
Cresilon is a biotechnology company that develops, manufactures, and markets hemostatic medical devices utilizing the company's proprietary hydrogel technology. Established in 2010, Cresilon is headquartered in Brooklyn, United States.Explore more
Cresilon Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cresilon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Cresilon
Cresilon, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Cresilon is spiking on competitors!
Check if Cresilon has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Cresilon has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Cresilon had a recent Job posting/layoffs
Product Launch: Get notified when Cresilon launches new products
Earning: See what the market has to say on Cresilon recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Cresilon
Compare insights from companies similar to Cresilon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cresilon is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cresilon is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cresilon.
Cresilon financials insights
Gather financial insights about Cresilon, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
2021
Series A
$38.5M
2022
Other Financing Round
$25M
2026
Debt
$5M
Cresilon Tech Stack
A closer look at the technologies used by Cresilon
Most Recent Scoops
Funding
Funding
Open Position
Hiring Plans
Cresilon has more open roles in Operations than it has had at any time in the past 6 months.
Hiring Plans
Open Position
Event
Product Marketing, Events, Training, Sales, Learning & Development, First Responder, Field /Outside Sales, Field Marketing, HR Operations
Cresilon News & Media
Cresilon Named One of the World's 50 Most Innovative Companies by Fast Company
Ranked No. 1 in the medical devices category and No. 46 on Fast Company's World's 50 Most Innovative Companies list NEW YORK, March 25, 2026 /PRNewswire/ -- Cresilon has been named to Fast Company's World's 50 Most Innovative Companies of 2026. The company ranked No. 1 in the medical...Cresilon Announces Poster Presentation on TRAUMAGEL Case Study at the 2026 Advanced Trauma Life Support Global Symposium
NEW YORK, March 12, 2026 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced that a retrospective clinical case series demonstrating the use of TRAUMAGEL®, in an emergency hemorrhagic trauma...Cresilon Receives Innovative Technology Contract from Vizient for TRAUMAGEL
Contract awarded for products that bring improvement to healthcare industry NEW YORK, March 2, 2026 /PRNewswire/ -- Cresilon announced its revolutionary hemostatic gel TRAUMAGEL® has received an Innovative Technology contract from Vizient® the nation's largest provider-driven healthcare...Cresilon Announces Poster Presentation on TRAUMAGEL Case Study at the 2025 Military Health System Research Symposium
NEW YORK, Aug. 4, 2025 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced that a case study demonstrating the clinical use of its FDA-cleared hemostatic medical device, TRAUMAGEL®, in an...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cresilon
Sign Up For FreeTo access detailed company insights
Cresilon is a biotechnology company that develops, manufactures, and markets hemostatic medical devices utilizing the company's proprietary hydrogel technology. Established in 2010, Cresilon is headquartered in Brooklyn, United States.... Read More
